The Bridge-Enhanced® ACL Repair (BEAR®) implant is a proprietary bio-engineered bridging scaffold to facilitate healing of the torn ACL.
The BEAR implant is designed to be surgically placed between the torn ACL ends at the time of repair, and to hold a small amount of the patient’s blood in the wound site. The combination of the BEAR implant and the patient’s blood provides a scaffold that allows the torn ends of the ACL to heal back together.
It is hoped this new technology will restore more normal anatomy and function of the knee, and thus enable a higher percentage of patients to get back to activities they enjoy.
The BEAR implant is an investigational device and is only available in FDA-approved clinical trials.
Watch this video to find out more about how the BEAR implant works.
Watch this video to find out more about ACL tears, the BEAR implant and the first patient to receive it.
Several clinical trials are underway to study the BEAR implant and its safety and efficacy.
American Journal of Sports Medicine: "Predictors of Healing Ligament Size and Magnetic Resonance Signal Intensity at 6 Months After Bridge-Enhanced Anterior Cruciate Ligament Repair." April 2019
Orthopedic Journal of Sports Medicine: "Bridge-Enhanced Anterior Cruciate Ligament Repair: Two-Year Results of a First-in-Human Study." March 2019
Journal of Orthopaedic Research: "Bench-to-Bedside: Bridge-Enhanced Anterior Cruciate Ligament Repair." July 2017
Orthopedic Journal of Sports Medicine: “The Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR) Procedure: An Early Feasibility Cohort Study.” November 2016
American Journal of Sports Medicine: "Use of a Bioactive Scaffold to Stimulate Anterior Cruciate Ligament Healing Also Minimizes Posttraumatic Osteoarthritis After Surgery." August 2013